Perceptive Advisors LLC 13D and 13G filings for Reata Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-03-07 11:25 am Purchase | 2023-03-06 | 13G | Reata Pharmaceuticals, Inc. RETA | Perceptive Advisors LLC | 2,083,799 6.500% | 2,083,799 (New Position) | Filing |